Tower Research Capital LLC TRC bought a new stake in Anthem Inc. (NYSE:ANTM) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,956 shares of the company’s stock, valued at approximately $257,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Panagora Asset Management Inc. raised its position in Anthem by 5.7% in the first quarter. Panagora Asset Management Inc. now owns 805,876 shares of the company’s stock worth $112,009,000 after buying an additional 43,632 shares in the last quarter. Renaissance Technologies LLC raised its position in Anthem by 41.4% in the first quarter. Renaissance Technologies LLC now owns 407,200 shares of the company’s stock worth $56,597,000 after buying an additional 119,300 shares in the last quarter. Nuveen Asset Management LLC raised its position in Anthem by 1.5% in the first quarter. Nuveen Asset Management LLC now owns 195,133 shares of the company’s stock worth $27,121,000 after buying an additional 2,833 shares in the last quarter. Adage Capital Partners GP L.L.C. raised its position in Anthem by 328.5% in the first quarter. Adage Capital Partners GP L.L.C. now owns 198,778 shares of the company’s stock worth $27,628,000 after buying an additional 152,390 shares in the last quarter. Finally, Legal & General Group Plc raised its position in Anthem by 0.9% in the first quarter. Legal & General Group Plc now owns 1,313,104 shares of the company’s stock worth $182,491,000 after buying an additional 11,822 shares in the last quarter. Institutional investors own 89.44% of the company’s stock.

Anthem Inc. (NYSE:ANTM) opened at 128.42 on Friday. The stock has a market cap of $33.80 billion, a P/E ratio of 14.85 and a beta of 0.45. The stock’s 50 day moving average price is $127.01 and its 200-day moving average price is $134.13. Anthem Inc. has a one year low of $115.63 and a one year high of $149.87.

Anthem (NYSE:ANTM) last released its quarterly earnings results on Wednesday, July 27th. The company reported $3.33 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.23 by $0.10. Anthem had a return on equity of 12.16% and a net margin of 2.83%. The firm had revenue of $21.27 billion for the quarter, compared to the consensus estimate of $20.53 billion. During the same quarter last year, the business posted $3.10 EPS. The company’s revenue for the quarter was up 7.7% on a year-over-year basis. On average, analysts predict that Anthem Inc. will post $10.89 earnings per share for the current year.

The company also recently declared a quarterly dividend, which will be paid on Monday, September 26th. Shareholders of record on Friday, September 9th will be paid a $0.65 dividend. This represents a $2.60 annualized dividend and a dividend yield of 2.02%. The ex-dividend date of this dividend is Wednesday, September 7th. Anthem’s dividend payout ratio is 30.06%.

ANTM has been the subject of a number of analyst reports. Sanford C. Bernstein started coverage on Anthem in a research report on Thursday, June 16th. They set an “outperform” rating and a $207.00 price objective for the company. Leerink Swann reaffirmed a “buy” rating and set a $160.00 target price on shares of Anthem in a research note on Thursday, June 16th. Citigroup Inc. reaffirmed a “buy” rating and set a $172.00 target price on shares of Anthem in a research note on Tuesday, June 21st. Wolfe Research started coverage on Anthem in a research note on Tuesday, June 28th. They set a “market perform” rating and a $168.00 target price on the stock. Finally, Zacks Investment Research downgraded Anthem from a “hold” rating to a “sell” rating in a research note on Tuesday, July 12th. Nine analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. The company currently has a consensus rating of “Buy” and an average price target of $161.86.

In other news, Director William J. Ryan sold 3,125 shares of the firm’s stock in a transaction dated Thursday, July 28th. The stock was sold at an average price of $133.15, for a total value of $416,093.75. Following the completion of the transaction, the director now owns 27,149 shares in the company, valued at approximately $3,614,889.35. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, EVP Gloria M. Mccarthy sold 4,786 shares of the firm’s stock in a transaction dated Friday, July 1st. The shares were sold at an average price of $131.23, for a total value of $628,066.78. Following the completion of the transaction, the executive vice president now owns 46,167 shares of the company’s stock, valued at approximately $6,058,495.41. The disclosure for this sale can be found here. 0.37% of the stock is owned by company insiders.

About Anthem

Anthem, Inc is a health benefit company. The Company offers a range of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. The Company has three segments: Commercial and Specialty Business, Government Business and Other. The Company’s Commercial and Specialty Business, and Government Business segments offer managed care products, including preferred provider organizations (PPOs), health maintenance organizations (HMOs), traditional indemnity benefits and point-of-service (POS) plans, as well as various hybrid benefit plans, including consumer-driven health plans (CDHPs), hospital only and limited benefit products.

5 Day Chart for NYSE:ANTM

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem Inc. (NYSE:ANTM).

Receive News & Ratings for Anthem Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem Inc. and related companies with MarketBeat.com's FREE daily email newsletter.